TELOMIR PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.33 USD | +15.47% |
|
-9.98% | 0.00% |
| 02/07 | Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes | MT |
| 01/07 | Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Small Cap Comp Value Index | CI |
Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acidâs (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 111M | |
| +56.89% | 809B | |
| +39.52% | 624B | |
| -6.55% | 351B | |
| +7.92% | 289B | |
| +13.74% | 240B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 166B | |
| -2.57% | 157B |
- Stock Market
- Equities
- TELO Stock
- News Telomir Pharmaceuticals, Inc.
- Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes
